QCD running in neutrinoless double beta decay: Short-range mechanisms

16 pages.- 3 figures.- 2 tablesThe decay rate of neutrinoless double beta (0 nu beta beta) decay contains terms from heavy particle exchange, which lead to dimension-9 (d = 9) six fermion operators at low energies. Limits on the coefficients of these operators have been derived previously neglecting the running of the operators between the high scale, where they are generated, and the energy scale of 0 nu beta beta decay, where they are measured. Here we calculate the leading-order QCD corrections to all possible d = 9 operators contributing to the 0 nu beta beta amplitude and use renormalization group running to calculate 1-loop improved limits. Numerically, QCD running dramatically changes some limits by factors of the order of or larger than typical uncertainties in nuclear matrix element calculations. For some specific cases, operator mixing in the running changes limits even by up to 3 orders of magnitude. Our results can be straightforwardly combined with new experimental limits or improved nuclear matrix element calculations to rederive updated limits on all short-range contributions to 0 nu beta beta decay.M. G. thanks the IFIC for hospitality during her stay. This work was supported by the Spanish MICINN Grants No. FPA2014-58183-P and Multidark CSD2009-00064 (MINECO), and PROMETEOII/2014/084 (Generalitat Valenciana), and by Fondecyt (Chile) under Grants No. 1150792 and No. 3160642.Peer reviewe

Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis

OBJECTIVE: To determine the impact of cervical excision for cervical intraepithelial neoplasia on fertility and early pregnancy outcomes. DESIGN: Systematic review and meta-analysis of cohort studies. DATA SOURCES: Medline and Embase. ELIGIBILITY CRITERIA: Studies assessing fertility and early pregnancy outcomes in women with a history of treatment for cervical intraepithelial neoplasia versus untreated women. We classified the included studies according to treatment type and fertility or early pregnancy endpoint. ANALYSIS: Pooled relative risks and 95% confidence intervals using a random effect model, and interstudy heterogeneity with I(2) statistics. RESULTS: 15 studies fulfilled the inclusion criteria and were included. The meta-analysis did not provide any evidence that treatment for cervical intraepithelial neoplasia adversely affected the chances of conception. The overall pregnancy rate was higher for treated women than for untreated women (four studies; 43% v 38%, pooled relative risk 1.29, 95% confidence interval 1.02 to 1.64), although the heterogeneity between studies was high (P<0.0001). Pregnancy rates did not differ between women with an intention to conceive (two studies; 88% v 95%, 0.93, 0.80 to 1.08) and the number requiring more than 12 months to conceive (three studies, 15% v 9%, 1.45, 0.89 to 2.37). Although the rates for total miscarriages (10 studies; 4.6% v 2.8%, 1.04, 0.90 to 1.21) and miscarriage in the first trimester (four studies; 9.8% v 8.4%, 1.16, 0.80 to 1.69) was similar for treated and untreated women, cervical treatment was associated with a significantly increased risk of miscarriage in the second trimester. The rate was higher for treated women than for untreated women (eight studies; 1.6% v 0.4%, 16,558 women; 2.60, 1.45 to 4.67). The number of ectopic pregnancies (1.6% v 0.8%; 1.89, 1.50 to 2.39) and terminations (12.2% v 7.4%; 1.71, 1.31 to 2.22) was also higher for treated women. CONCLUSION: There is no evidence suggesting that treatment for cervical intraepithelial neoplasia adversely affects fertility, although treatment was associated with a significantly increased risk of miscarriages in the second trimester. Research should explore mechanisms that may explain this increase in risk and stratify the impact that treatment may have on fertility and early pregnancy outcomes by the size of excision and treatment method used

Neutrinoless double beta decay and lepton number violation at the LHC

10.1103/PhysRevD.88.011901This work was supported by EU Network Grant No. UNILHC PITN-GA-2009-237920 and by the Spanish MICINN Grants No. FPA2011-22975 and No. MULTIDARK CSD2009-00064, by the Generalitat Valenciana (Prometeo/2009/091), by Fondecyt Grants No. 11121557 and No. 1100582, and CONICYT Projects No. 791100017 and No. CONICYT/DFG-648. H. P. was supported by DGF Grant No. PA 803/6-1.Peer reviewe

Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.

© Queen’s Printer and Controller of HMSO 2013. This work was produced by Meads et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising.Cancer of the uterine cervix is a common cause of mortality in women. After initial treatment women may be symptom free, but the cancer may recur within a few years. It is uncertain whether it is more clinically effective to survey asymptomatic women for signs of recurrence or to await symptoms or signs before using imaging.National Institute for Health Research Health Technology Assessment programm

Evaluating PET-CT in the detection and management of recurrent cervical cancer: Systematic reviews of diagnostic accuracy and subjective elicitation

Background: Positron emission tomography-computed tomography (PET-CT) is recommended to triage women for exenterative surgery and surveillance after treatment for advanced cervical cancer. Objective: To evaluate diagnostic accuracy of additional whole body PET-CT compared with CT/magnetic resonance imaging (MRI) alone in women with suspected recurrent/persistent cervical cancer and in asymptomatic women as surveillance. Design: Systematic reviews. Subjective elicitation to supplement diagnostic information. Search strategy/Selection criteria/Data collection and analysis: Searches of electronic databases were performed to June 2013. Studies in women with suspected recurrent/persistent cervical cancer and in asymptomatic women undergoing follow up with sufficient numeric data were included. We calculated sensitivity, specificity and corresponding 95% confidence intervals. Meta-analyses employed a bivariate model that included a random-effects term for between-study variations (CT studies) and univariate random effects meta-analyses (PET-CT studies) for sensitivity and specificity separately. Subjective elicitation: Prevalence of recurrence and the accuracy of imaging elicited using the allocation of points technique. Coherence of elicited subjective probabilities with estimates in the literature examined. Results: We identified 15 relevant studies; none directly compared additional PET-CT with MRI or CT separately. Most CT and MRI studies used older protocols and the majority did not distinguish between asymptomatic and symptomatic women. Meta-analysis of nine PET-CT studies in mostly symptomatic women showed sensitivity of 94.8 (95% CI 91.2-96.9), and specificity of 86.9% (95% CI 82.2-90.5). The summary estimate of the sensitivity of CT for detection of recurrence was 89.64% (95% CI 81.59-94.41) and specificity was 76% (95% CI 43.68-92.82). Meta-analysis for MRI test accuracy studies was not possible because of clinical heterogeneity. The sensitivity and specificity of MRI in pelvic recurrence varied between 82 and 100% and between 78 and 100%, respectively. Formal statistical comparisons of the accuracy of index tests were not possible. Subjective elicitation provided estimates comparable to the literature. Subjective estimates of the increase in accuracy from the addition of PET-CT were less than elicited increases required to justify the use in PET-CT for surveillance. Conclusion: Evidence to support additional PET-CT is scarce, of average quality and does not distinguish between application for surveillance and diagnosis. Guidelines recommending PET-CT in recurrent cervical cancer need to be reconsidered in the light of the existing evidence base

Multiple Histogram Method for Quantum Monte Carlo

An extension to the multiple-histogram method (sometimes referred to as the Ferrenberg-Swendsen method) for use in quantum Monte Carlo simulations is presented. This method is shown to work well for the 2D repulsive Hubbard model, allowing measurements to be taken over a continuous region of parameters. The method also reduces the error bars over the range of parameter values due the overlapping of multiple histograms. A continuous sweep of parameters and reduced error bars allow one to make more difficult measurements, such as Maxwell constructions used to study phase separation. Possibilities also exist for this method to be used for other quantum systems.Comment: 4 pages, 5 figures, RevTeX, submitted to Phys. Rev. B Rapid Com

Experimental tests for the Babu-Zee two-loop model of Majorana neutrino masses

The smallness of the observed neutrino masses might have a radiative origin. Here we revisit a specific two-loop model of neutrino mass, independently proposed by Babu and Zee. We point out that current constraints from neutrino data can be used to derive strict lower limits on the branching ratio of flavour changing charged lepton decays, such as $\mu \to e \gamma$. Non-observation of Br($\mu \to e \gamma$) at the level of $10^{-13}$ would rule out singly charged scalar masses smaller than 590 GeV (5.04 TeV) in case of normal (inverse) neutrino mass hierarchy. Conversely, decay branching ratios of the non-standard scalars of the model can be fixed by the measured neutrino angles (and mass scale). Thus, if the scalars of the model are light enough to be produced at the LHC or ILC, measuring their decay properties would serve as a direct test of the model as the origin of neutrino masses.Comment: 14 pages, 16 figure

Proceedings of the 2nd Workshop on Flavor Symmetries and Consequences in Accelerators and Cosmology (FLASY12)

These are the proceedings of the 2nd Workshop on Flavor Symmetries and Consequences in Accelerators and Cosmology, held 30 June 2012 - 4 July 2012, Dortmund, Germany

Right-handed Sneutrinos as Nonthermal Dark Matter

When the minimal supersymmetric standard model is augmented by three right-handed neutrino superfields, one generically predicts that the neutrinos acquire Majorana masses. We postulate that all supersymmetry (SUSY) breaking masses as well as the Majorana masses of the right-handed neutrinos are around the electroweak scale and, motivated by the smallness of neutrino masses, assume that the lightest supersymmetric particle (LSP) is an almost-pure right-handed sneutrino. We discuss the conditions under which this LSP is a successful dark matter candidate. In general, such an LSP has to be nonthermal in order not to overclose the universe, and we find the conditions under which this is indeed the case by comparing the Hubble expansion rate with the rates of the relevant thermalizing processes, including self-annihilation and co-annihilation with other SUSY and standard model particles.Comment: 17 pages v.2: References adde